Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5219_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Foreword
- •Preface
- •Contents
- •Editors and Contributors
- •About the Editors
- •Contributors
- •1.1 Introduction
- •1.2 Conventional Methods
- •1.2.1 Microscopy
- •1.2.2 Culture
- •1.2.3 Germ Tube Test
- •1.2.5 Carbohydrate Assimilation Test
- •1.2.6 Nitrogen Assimilation Test
- •1.2.7 Carbohydrate Fermentation Test
- •1.2.8 Urease Test
- •1.2.9 Tween 80 Opacity Test
- •1.3 Nonculture-Based Conventional Methods
- •1.3.1 Serological Methods
- •1.3.1.2 ß-d-Glucan
- •1.3.1.3 C. albicans Germ Tube Antibody Assay (CAGTA)
- •1.4 Nucleic Acid-Based Detection
- •1.4.1 Polymerase Chain Reaction (PCR)
- •1.4.3 Peptide Nucleic Acid FISH (PNA-FISH)
- •1.4.4 PCR-Based Innovative Diagnosis
- •1.4.5 FilmArray System
- •1.4.6 Sepsis Flow Chip
- •1.4.7 ePlex System
- •1.4.8 The T2 Candida Assay
- •1.5 Rapid Identification Systems
- •1.5.1 Manual Rapid Identification System
- •1.5.1.1 The API System
- •1.5.1.2 The VITEK System
- •1.5.2 Automatic Rapid Identification System
- •1.5.2.1 MALDI-TOF MS
- •1.5.2.2 The MALDI Sepsityper IVD Kit
- •1.5.2.3 The BioFire FilmArray BCID2 Panel
- •1.5.2.4 The Accelerate Pheno BC Panel
- •1.6 Advanced Diagnostics
- •1.6.2 Biosensor-Based Tests
- •1.6.3 Next-Generation Sequencing (NGS)
- •1.7 Conclusion
- •References
- •2.1 Introduction
- •2.2.1.2 Echinocandins
- •First-Generation Echinocandin
- •Second-Generation Echinocandin
- •2.2.1.3 Other Cell Wall Inhibitors
- •2.2.2.1 Azoles
- •Imidazole
- •Triazole
- •Second-Generation Azole
- •Third-Generation Azole
- •2.2.2.2 Polyenes
- •Other Polyene Under Development
- •2.2.2.3 Allylamines
- •2.2.3 Flucytosine
- •2.3 Conclusion
- •References
- •3.1 Introduction
- •3.2.1 Control Diet
- •3.2.3 Toxification
- •3.2.4 Alternative Treatments
- •3.3.1 Prophylaxis
- •3.3.2 Preemptive Therapies
- •3.3.3 Empirical Therapies
- •3.4 Therapeutic Approach
- •3.4.1 Azoles
- •3.4.2 Echinocandins
- •3.4.3 Polyenes
- •References
- •4.1 Introduction
- •4.3 Eukarya Domain
- •4.4.1 Cryptococcus
- •4.4.2 Aspergillus
- •4.4.3 Mucorales
- •4.4.4 Candida
- •4.5.1 Candida albicans
- •4.5.2 Morphogenesis
- •4.5.3 Pathogenesis
- •4.5.4 Adherence
- •4.5.5 Morphological Switching
- •4.5.6 Invasion
- •4.6 Induced Endocytosis
- •4.7 Active Penetration
- •4.8.2 Biofilm Formation
- •4.8.4.1 Antifungals
- •4.8.4.2 Antifungal Resistance
- •References
- •5.1 Introduction
- •5.2.3.1 Serum
- •5.2.3.2 Low Nitrogen
- •5.2.3.5 Carbon Source
- •5.2.3.6 pH
- •5.2.3.7 N-acetylglucosamine (GlcNAc)
- •5.2.3.8 Quorum Sensing Molecule
- •5.5.5 Surface Colonization Factor1 (SCF1)
- •5.5.6 Other Putative Adhesins
- •5.6.1 Phospholipases
- •5.6.2 Proteinases
- •5.6.3 Hemolysins
- •5.6.4 Lipases
- •5.7 Secreted Cytolytic Peptide: Candidalysin
- •5.5.1 ALS Family
- •5.5.2 HWP Adhesin
- •5.5.3 HYR/IFF Family
- •5.5.4 EPA Family
- •5.9.2 Low Molecular Weight Hsp/Small Heat Shock Proteins
- •5.10.1 Amino Acid/Nitrogen Metabolism
- •5.10.1.1 Amino Acid Sensing Pathway
- •5.12.1.1 Glycolysis
- •5.12.1.2 Gluconeogenesis
- •5.12.1.3 Glyoxylate Cycle
- •5.12.1.4 Fatty Acid Oxidation
- •5.12.3.2 Iron Metabolism
- •5.12.3.3 Candida Iron Transport
- •5.12.3.4 Reductive System
- •5.12.3.5 Siderophore Uptake System
- •5.12.3.6 Haemoglobin-Iron Uptake System
- •5.13.2 Zinc Metabolism
- •References
- •6.1 Introduction
- •6.2 Morphological Switching
- •6.3 Phenotypic Switching
- •6.4 Biofilm Formation
- •6.5 Metabolic Flexibility
- •6.8.1 Hemolysin
- •6.8.2 Phospholipases
- •6.8.3 Proteinase
- •6.8.4 Candidalysin
- •6.12 Conclusion
- •References
- •7.1 Introduction
- •7.2.4 Polymorphism
- •7.2.5.1 Secreted Aspartyl Proteinases
- •7.2.5.2 Phospholipase
- •7.2.6 Calcineurin-Signalling Pathway
- •7.2.7 Ion Homeostasis
- •7.2.7.1 Iron
- •7.2.7.2 Copper
- •7.2.8.1 Capsule
- •7.2.8.2 Melanin
- •7.2.8.3 Heat Shock Proteins
- •7.3 Conclusions
- •References
- •8.1 Introduction
- •8.4.1 ATP-Binding Cassette (ABC) Transporters
- •8.4.2 Major Facilitator Superfamily (MFS) Transporter
- •8.5.1 Biofilm Architecture Among Candida Species
- •References
- •9.1 Introduction
- •References
- •10.1 Introduction
- •10.3 Biofilm
- •10.5 Adherence
- •10.6 Maturation
- •10.8 Dispersion
- •10.11 Animal Models
- •10.18 Photodynamic Therapy
- •References
- •11.1 Introduction
- •11.9 Concluding Remarks
- •References
- •12.1 Introduction
- •12.2 Epidemiology
- •12.3.1 Humoral Response
- •12.3.2 Cellular Immunity
- •12.4 Virulence Factors
- •12.6.1 Fluconazole
- •12.6.2 Polyenes
- •12.6.3 Echinocandins
- •12.7 Drug Resistance
- •12.8 Future Prospects
- •12.9 Conclusions
- •References
- •13.1 Introduction
- •13.4 Translation Research
- •13.4.1 Disease-Oriented Translational Research
- •13.4.2 Lab-Oriented Translational Research
- •13.4.3 Patient-Oriented Translational Research
- •13.5 Conclusion
- •References
- •14.1 Introduction
- •14.2.3 Cutaneous Aspergillosis
- •14.2.4 Ocular Aspergillosis
- •14.2.5 Aspergillus Endocarditis
- •14.2.6 Aspergillus Osteomyelitis
- •14.2.7 Sinus Aspergillosis
- •14.3.2 Histopathology
- •14.3.3 Serological
- •14.3.4 Breath Testing
- •14.3.5 Monoclonal Antibody (mAbs)-Mediated Methods
- •14.4.1 Conventional Therapeutics
- •14.4.1.1 Azoles
- •14.4.1.2 Polyenes
- •14.4.1.3 Echinocandins
- •14.4.1.4 Fluoropyrimidines
- •14.5 Nonconventional Therapeutics
- •14.5.1 Vaccine
- •14.5.2 Monoclonal Antibodies (mAbs)
- •14.5.3 Nanotechnology-Based Therapeutics
- •14.5.4 Immune Therapy
- •14.5.5 Combination Therapy
- •14.8 Conclusion
- •References
- •15: Aspergillus Therapeutics: Future Agents
- •15.1 Introduction
- •15.2.1 Fosmanogepix
- •15.2.2 Ibrexafungerp
- •15.2.3 Olorofim
- •15.2.4 Opelconazole
- •15.2.5 Rezafungin
- •15.2.6 MGCD290
- •15.2.7 Tetrazoles (VT-1129/VT-1161/VT-1598)
- •15.2.8 Nikkomycin Z
- •15.2.9 VL-2397
- •15.2.10 T-2307/ATI-2307
- •15.2.11 Encochleated Amphotericin-B
- •15.2.12 SUBA-Itraconazole
- •15.2.13 Immunotherapy
- •15.2.14 Drug Repurposing
- •References
- •16.1 Introduction
- •16.2 Antifungal Agents
- •16.2.1 Azoles
- •16.2.2 Posaconazole
- •16.2.3 Isavuconazole
- •16.2.4 SUBA—Itraconazole
- •16.2.5 Nanovoriconazole
- •16.2.6 Adverse Effects
- •16.3 Liposomal Amphotericin B (LAMB)
- •16.3.1 Echinocandins
- •16.4 Combination Antifungal Therapy
- •16.5 Therapeutic Drug Monitoring (TDM)
- •16.5.1 Azole-Resistant Aspergillus Spp.
- •16.6 Guideline Recommendations
- •16.10 Conclusion
- •References
- •17.1 Introduction
- •17.3 Potent Antifungal Molecules Under Investigations
- •References
- •19.2 Host–A. fumigatus Interactions
- •19.3.1 Hydrophobicity or Rodlet Layer
- •19.3.2 Conidiation
- •19.3.3 DHN Melanin
- •19.3.5 Siderophores
- •19.3.6 Biofilm Formation
- •19.4 Conclusion
- •References

7 Factors Aecting Drug Resistance andVirulence inFungal Pathogen
189
7.2.7.1 Iron
Iron is an essential trace element required for the survival and virulence of many
pathogenic fungal species. It is required for all important processes, including DNA
replication and repair, oxidative phosphorylation, the TCA cycle, detoxication of
oxidative stress, the activity of P450 enzymes, and the production of amino acids,
nucleotides, and sterols. The function of numerous enzymes depends on iron or
iron-containing cofactors, such as mononuclear or binuclear non-heme iron centres,
iron-sulfur (Fe-S) clusters, heme, and siroheme (Chen etal. 2011) and inuences
the mitogen-activated protein kinase (MAPK) pathway, which promotes virulence
by controlling adhesion and biolm formation (Puri etal. 2014; Kaba etal. 2013).
Iron is generally present in the ferrous form, but fungal cells, including C. albicans,
cannot directly take up this insoluble iron form, but must rst convert it to ferric iron
by the membrane-bound ferric reductase encoded by CaCFL1 (Hammacott etal.
2000). The iron ion is taken up in ferrous form by the iron transporters Ftr1 and
Ftr2. Iron levels control Hap43-dependent genes that regulate a variety of functions,
including adhesion, ribosome biogenesis, and low nitrogen-induced lament formation. A Hap43 mutant has been reported to result in delayed virulence (Singh etal.
2011). In an iron-decient environment, Candida utilizes the high-afnity iron
membrane permease encoded by CaFTR1, which affects the virulence of C. albi-
cans (Ramanan and Wang 2000). Knockout mutants of CaFTRl show severe growth
defects under iron-limiting conditions and are avirulent in the mouse (Ramanan and
Wang 2000). A similar pattern is seen with iron chelators such as bathophenanthroldisulfonic acid (BPS), ferrozine, and deferoxamine (DFO), which increase the
drug sensitivity of C. albicans. The main cause of this sensitivity is a decreased iron
level, which leads to a~30% decrease in ergosterol levels in the membrane and
increases membrane uidity, allowing better drug uptake. In iron-depleted cells, the
Erg11 content is signicantly reduced, which explains the reason for this sensitivity
of the pathogen (Prasad etal. 2006). Thus, drug sensitivity to azoles is related to the
cellular iron content that has been demonstrated in combination studies (Prasad
etal. 2006). The iron chelator DFO in combination with uconazole shows synergy
with a Fractional Inhibition Concentration Index (FICI) of 0.25. This combination
inhibits hyphal induction and suppresses the expression of the adhesion gene ASL1
in the FLC-resistant strain of C. albicans (An etal. 2022). In recurrent vulvovaginal
candidiasis patients with low iron levels, the virulence of the pathogen is impaired
due to reduced invasion of the host epithelium (Spacek etal. 2005). Interestingly,
Cir1, an iron-responsive transcription factor in C. neoformans, regulates its thermotolerance, melanin synthesis, and capsule formation. Cir knockouts exhibit reduced
melanin levels and capsule production, are less thermotolerant, and become avirulent (Jung etal. 2006). The iron chelator DFO also shows synergistic effects with
AmpB in C. neoformans and the MIC value decreases ve-fold (Chayakulkeeree
etal. 2020).
7.2.7.2 Copper
Although copper is required for many eukaryotic functions including enzymatic
activity, its role in fungal drug resistance is not direct. In fungi, the conversion of

190
P. Sharma et al.
Cu2+ to Cu+ is required for the functioning of copper-dependent enzyme-catalysed
reactions, needed for biological processes such as iron uptake and transport, respiration, superoxide detoxication, and melanin formation (Samanovic etal. 2012).
Copper uptake involves a low-afnity transporter protein, Fet4, and three highafnity copper transporters, Ctr1, Ctr2, and Ctr3 (Song etal. 2019). Ctr1 and Ctr3
are present at the cell membrane for copper uptake, while Ctr2 is a vacuolar membrane protein that mobilizes cytosolic copper. Atx1 and Ccs1 are the two cytosolic
copper chaperones that bind to copper and transfer it to the Cu+ ATPase pump
(Ccc2) and superoxide dismutase 1 (Sod1) (Li etal. 2019). Atx1p also transfers copper to Fet3p, which is responsible for both copper and iron uptake (Lin etal. 1997).
Sod1, which is involved in ROS detoxication, leads to attenuated virulence of the
fungus in the mouse model of C. neoformans (Cox etal. 2003). Atx1 and Ccc2 are
involved in the copper-mediated function of laccase (Lac1), which is needed for
melanin production in C. neoformans. ATX1 and CCC2 genes disrupted in ST309A
and ST239D strains show similar phenotypes of reduced melanin production, as
Lac1 mutant (Walton et al. 2005). To modulate copper responses, Candida and
S. cerevisiae require two transcription factors, Mac1 and Ace1, which are function-
ally reciprocal copper metalloregulators. Under copper-decient conditions, Mac1
controls the expression of CTR1, CTR3, and FRE1 genes (Keller et al. 2005).
Mutated Mac1in C. albicans leads to growth defects (Yamaguchi-Iwai etal. 1997).
In A. fumigatus, the double deletion of the high-afnity copper uptake proteins
CTRA2 and CTRC leads to a reduction in intracellular copper levels and thus to
growth and sporulation abnormalities in copper-decient dened media (Cai etal.
2017; Park etal. 2014). Deletion of another gene for the high-afnity transporter
CTRB leads to signicant abnormalities in hyphal development in copper-rich and
copper-poor environments (Cai etal. 2017).
7.2.8 Other Factors Responsible forDrug Resistance
7.2.8.1 Capsule
Like bacteria, certain fungal species are also encapsulated, e.g. C. neoformans, and
this is the main source of virulence of this fungus (McFadden etal. 2006). Two
polysaccharides, GXM and galactoxylomannan (GalXM), together with a small
amount of mannoproteins (MPs), make up most of the composition of the capsule.
The rst response that C. neoformans elicits in a variety of hosts such as amoebae,
mammals, and insects is expansion of the capsule. The GXM of the capsule gives it
the outstanding ability to resist phagocytosis (Angiolella 2022). The capsule is
expressed by the CAP59 and CAP64 genes, and deletion of CAP59 results in an
acapsular cell of C. neoformans that is associated with loss of virulence (Zaragoza
etal. 2009). The size of the capsule can vary depending on environmental conditions, including CO2 and serum. Studies suggest that cells with an expanded capsule
have greater resistance to antifungal drugs, antimicrobial peptides, and oxidative
stress (Zaragoza 2019).

7 Factors Aecting Drug Resistance andVirulence inFungal Pathogen
191
7.2.8.2 Melanin
Melanin inuences the host’s immunological response by reducing the susceptibility of the pathogen and increases the virulence of fungi (Nosanchuk etal. 2015).
Melanin is a dark brown pigment produced by some fungal species through the
oxidative polymerization of phenolic substances such as glutaminyl-3,4dihydroxybenzene (GDHB), catechol, 1,8-dihydroxynaphthalene (DHN), and
3,4-dihydroxyphenylalanine (DOPA) (Eisenman et al. 2009). This pigment is
known as ‘fungal armour’ because it protects the fungus from harmful conditions by
scavenging oxidants produced in response to stress. Other biological effects of melanin include thermoregulation, radio- and photoprotection, antibacterial activity,
phagocytosis, cytotoxicity, antiviral activity, anti-inammation, and immunomodulation (Fig.7.5) (Pombeiro-Sponchiado etal. 2017). One of the most intensively
researched melanization pathogens is C. neoformans. C. neoformans differs from
other pathogenic fungi in that it uses only the L-DOPA pathway and does not require
foreign phenolic substrates to produce melanin. Melanin is responsible for 14% of
total pathogenicity. This makes it the second most important virulence component
of C. neoformans after the polysaccharide capsule. In C. neoformans, melanization
takes place in special vesicles known as melanosomes (Eisenman etal. 2009). The
virulence and survival of C. neoformans in macrophages are associated with a laccase that has been shown to synthesize melanin. Since laccase production is controlled by the LAC1 and LAC2 genes, the ability of C. neoformans to survive in
macrophages decreases when both genes are removed (Missall etal. 2005). During
co-incubation with macrophages, melanin increases the survival of C. neoformans.
Studies show that melanized C. neoformans cells in the lung and brain of mice have
a greater fungal burden than non-melanized cells. Compared to non-melanized
cells, melanized cells can survive longer in phagolysosomes (Baker and Casadevall
2023). In C. auris, catecholamines and L-DOPA are oxidized to melanin. The non-
enzymatic oxidation of L-DOPA to melanin adheres to the surface of C. auris
through alkalinization of the extracellular medium. The genome of C. auris contains tyrosinases, laccases, and phenol oxidases, all of which are associated with the
production of melanin in other fungi. By alkalinizing the medium with ammonia,
which increases the non-enzymatic oxidation of catecholamines, clade I, IV, and V
strains of C. auris synthesize melanin extracellularly, and the melanin-producing
clades are resistant to oxidative stress (Smith etal. 2022). A. fumigatus can produce
three different forms of melanin: extracellular water-soluble pyomelanin, DHN
melanin, and DOPA melanin immobilized on the cell wall when the medium contains either L-tyrosine or L-phenylalanine. These secondary metabolites consist of
complex polymers of phenolic or indolic monomers. The production of DHN melanin in A. fumigatus begins during conidiation and is responsible for their greenishgrey colour (Perez-Cuesta etal. 2020). Disruption of the gene for the PksP enzyme,
which is responsible for the initiation of the DHN melanin synthesis, leads to the
formation of white spores with reduced virulence. Pyomelanin, on the other hand,
protects the fungus from oxidative and cell wall stress (Heinekamp etal. 2013).

192
P. Sharma et al.
7.2.8.3 Heat Shock Proteins
Heat shock proteins (HSPs) are proteins that exhibit upregulation in response to
stress induction and temperature change and those that show a high sequence similarity to recognized categories of HSPs (Chatterjee and Tatu 2017). During infection, human fungal pathogens are subjected to several conditions, including exposure
to the host’s body temperature and immune system. Hsp90 and Hsp70 strongly
favour the morphological alterations necessary for virulence, resistance to antifungal drugs, and thermotolerance (Fig. 7.2) (Horianopoulos and Kronstad 2021).
Hsp90in C. albicans is crucial for temperature-dependent morphological changes
at 37°C and for the organism to tolerate echinocandins. Transcriptional repression
of Hsp90 leads to an impaired yeast-to-hyphae transition in C. albicans and deletion
of HSP90 (Δhsp90) also leads to reduced virulence (Shapiro etal. 2009). Hsp90
similarly plays an important role in cell wall integrity in A. fumigatus by interacting
with the kinases MpkA and PkcA as well as RlmA.Inhibition of Hsp90 impairs cell
integrity and renders A. fumigatus thermosensitive (Rocha etal. 2021). Chemical
inhibition of Hsp90in C. neoformans revealed its importance for capsule development, thermotolerance at 37 and 39°C, tolerance to antifungal drugs, and virulence
in a Caenorhabditis elegans model (Chatterjee and Tatu 2017).
7.3 Conclusions
It can be concluded that various factors contribute to drug resistance and virulence,
such as the ABC and MFS transporters, which belong to two large protein superfamilies, some of which have evolved into drug transporters. Drug targets and/or
intracellular drug concentrations are directly affected by genetic changes leading to
resistance to antifungal agents, with heritable effects on the entire cell population.
Several fungal species such as Candida and Cryptococcus are involved in melanin
production and biolm formation, which is another critical factor that increases the
Fig. 7.5 Pathogenic role of melanization on fungal cells

7 Factors Aecting Drug Resistance andVirulence inFungal Pathogen
193
pathogenicity of fungal species. Phospholipase and protease are some examples of
secreted enzymes that can increase the virulence of human pathogenic fungi.
Acknowledgments Funding: R. Pasrija thanks the ‘Science & Engineering Research Board
(CRG/2020/004986) under Department of Science and Technology’ for funding. P. Sharma
acknowledges the ‘Maharshi Dayanand University’, Rohtak, for the nancial support for University
Research Scholarship.
References
Akins RA (2005) An update on antifungal targets and mechanisms of resistance in Candida albi-
cans. Med Mycol 43:285–318. https://doi.org/10.1080/13693780500138971
Albarrag AM, Anderson MJ, Howard SJ, Robson GD, Warn PA, Sanglard D, Denning DW (2011)
Interrogation of related clinical pan-azole-resistant Aspergillus fumigatus strains: G138C,
Y431C, and G434C single nucleotide polymorphisms in cyp51A, upregulation of cyp51A,
and integration and activation of transposon Atf1in the cyp51A promoter. Antimicrob Agents
Chemother 55:5113–5121. https://doi.org/10.1128/aac.00517- 11
An L, Tan J, Wang Y, Liu S, Li Y, Yang L (2022) Synergistic effect of the combination of def-
eroxamine and uconazole in vitro and in vivo against uconazole-resistant Candida Spp.
Antimicrob Agents Chemother 66:e00725–e00722. https://doi.org/10.1128/aac.00725- 22
Angiolella L (2022) Virulence regulation and drug-resistance mechanism of fungal infection.
Microorganisms 10:409. https://doi.org/10.3390/microorganisms10020409
Asadzadeh M, Mokaddas E, Ahmad S, Abdullah AA, de Groot T, Meis JF, Shetty SA (2022)
Molecular characterisation of Candida auris isolates from immunocompromised patients in a
tertiary-care hospital in Kuwait reveals a novel mutation in FKS1 conferring reduced suscepti-
bility to echinocandins. Mycoses 65:331–343. https://doi.org/10.1111/myc.13419
Aslanyan L, Sanchez DA, Valdebenito S, Eugenin EA, Ramos RL, Martinez LR (2017) The crucial
role of biolms in Cryptococcus neoformans survival within macrophages and colonization of
the central nervous system. J Fungi 3:10. https://doi.org/10.3390/jof3010010
Bader T, Bodendorfer B, Schröppel K, Morschhäuser J (2003) Calcineurin is essential for
virulence in Candida albicans. Infect Immun 71:5344–5354. https://doi.org/10.1128/
IAI.71.9.5344- 5354.2003
Baker RP, Casadevall A (2023) Reciprocal modulation of ammonia and melanin production
has implications for cryptococcal virulence. Nat Commun 14:849. https://doi.org/10.1038/
s41467- 023- 36552- 7
Barman A, Gohain D, Bora U, Tamuli R (2018) Phospholipases play multiple cellular roles
including growth, stress tolerance, sexual development, and virulence in fungi. Microbiol Res
209:55–69. https://doi.org/10.1016/j.micres.2017.12.012
Behnsen J, Lessing F, Schindler S, Wartenberg D, Jacobsen I, Thoen M, Zipfel P, Brakhage A
(2010) Secreted Aspergillus fumigatus protease Alp1 degrades human complement proteins
C3, C4, and C5. Infect Immun 78:3585–3594. https://doi.org/10.1128/IAI.01353- 09
Beis K (2015) Structural basis for the mechanism of ABC transporters. Biochem Soc Trans
43:889–893. https://doi.org/10.1042/BST20150047
Berman J, Krysan DJ (2020) Drug resistance and tolerance in fungi. Nat Rev Microbiol 18:319–331.
https://doi.org/10.1038/s41579- 019- 0322- 2
Bongomin F, Gago S, Oladele RO, Denning DW (2017) Global and multi-national prevalence of
fungal diseases—estimate precision. J Fungi 3:57. https://doi.org/10.3390/jof3040057
Branco J, Ola M, Silva RM, Fonseca E, Gomes NC, Martins-Cruz C, Silva AP, Silva-Dias
A, Pina-Vaz C, Erraught C, Brennan L, Rodrigues AG, Butler G, Miranda IM (2017)
Impact of ERG3 mutations and expression of ergosterol genes controlled by UPC2 and

194
NDT80 in Candida parapsilosis azole resistance. Clin Microbiol Infect 23:575.e1–575.e8.
https://doi.org/10.1016/j.cmi.2017.02.002
Braun BR, Johnson AD (1997) Control of lament formation in Candida albicans by the transcrip-
tional repressor TUP1. Science 277:105–109. https://doi.org/10.1126/science.277.5322.105
Brown GD, Denning DW, Gow NAR, Levitz SM, Netea MG, White TC (2012) Hidden killers: human
fungal infections. Sci Transl Med 4:165rv13. https://doi.org/10.1126/scitranslmed.3004404
Cai Z, Du W, Zeng Q, Long N, Dai C, Lu L (2017) Cu-sensing transcription factor Mac1 coor-
dinates with the Ctr transporter family to regulate Cu acquisition and virulence in Aspergillus
fumigatus. Fungal Genet Biol 107:31–43. https://doi.org/10.1016/j.fgb.2017.08.003
Cao C, Wang Y, Husain S, Soteropoulos P, Xue C (2019) A mechanosensitive channel governs lipid
ippase-mediated echinocandin resistance in Cryptococcus neoformans. MBio 10:e01952-19.
https://doi.org/10.1128/mbio.01952- 19
Chatterjee S, Tatu U (2017) Heat shock protein 90 localizes to the surface and augments viru-
lence factors of Cryptococcus neoformans. PLoS Negl Trop Dis 11:e0005836. https://doi.
org/10.1371/journal.pntd.0005836
Chau AS, Gurnani M, Hawkinson R, Laverdiere M, Cacciapuoti A, McNicholas PM (2005)
Inactivation of sterol Δ5,6-desaturase attenuates virulence in Candida albicans. Antimicrob
Agents Chemother 49:3646–3651. https://doi.org/10.1128/aac.49.9.3646- 3651.2005
Chayakulkeeree M, Tangkoskul T, Waywa D, Tiengrim S, Pati N, Thamlikitkul V (2020) Impact of
iron chelators on growth and expression of iron-related genes of Cryptococcus species. J Mycol
Med 30:100905. https://doi.org/10.1016/j.mycmed.2019.100905
Chen C, Pande K, French SD, Tuch BB, Noble SM (2011) An iron homeostasis regulatory circuit
with reciprocal roles in Candida albicans commensalism and pathogenesis. Cell Host Microbe
10:118–135. https://doi.org/10.1016/j.chom.2011.07.005
Chen Y, Shi ZW, Strickland AB, Shi M (2022) Cryptococcus neoformans infection in the central
nervous system: the battle between host and pathogen. J Fungi (Basel) 8:1069. https://doi.
org/10.3390/jof8101069
Clarke SC, Dumesic PA, Homer CM, O’Donoghue AJ, Greca FL, Pallova L, Majer P, Madhani
HD, Craik CS (2016) Integrated activity and genetic proling of secreted peptidases in
Cryptococcus neoformans reveals an aspartyl peptidase required for low pH survival and viru-
lence. PLoS Pathog 12:e1006051. https://doi.org/10.1371/journal.ppat.1006051
Costa C, Dias PJ, Sá-Correia I, Teixeira MC (2014) MFS multidrug transporters in patho-
genic fungi: do they have real clinical impact? Front Physiol 5:197. https://doi.org/10.3389/
fphys.2014.00197
Cottier F, Sherrington S, Cockerill S, del Olmo TV, Kissane S, Tournu H, Orsini L, Palmer GE, Pérez
JC, Hall RA (2019) Remasking of Candida albicans β-glucan in response to environmental pH
is regulated by quorum sensing. mBio 10:e02347-19. https://doi.org/10.1128/mBio.02347- 19
Cowen LE, Sanglard D, Howard SJ, Rogers PD, Perlin DS (2015) Mechanisms of antifungal
drug resistance. Cold Spring Harb Perspect Med 5:a019752. https://doi.org/10.1101/cshper-
spect.a019752
Cox GM, McDade HC, Chen SCA, Tucker SC, Gottfredsson M, Wright LC, Sorrell TC, Leidich
SD, Casadevall A, Ghannoum MA, Perfect JR (2001) Extracellular phospholipase activity
is a virulence factor for Cryptococcus neoformans. Mol Microbiol 39:166–175. https://doi.
org/10.1046/j.1365- 2958.2001.02236.x
Cox GM, Harrison TS, McDade HC, Taborda CP, Heinrich G, Casadevall A, Perfect JR (2003)
Superoxide dismutase inuences the virulence of Cryptococcus neoformans by affect-
ing growth within macrophages. Infect Immun 71:173–180. https://doi.org/10.1128/
IAI.71.1.173- 180.2003
Csank C, Makris C, Meloche S, Schröppel K, Röllinghoff M, Dignard D, Thomas DY, Whiteway
M (1997) Derepressed hyphal growth and reduced virulence in a VH1 family-related protein
phosphatase mutant of the human pathogen Candida albicans. Mol Biol Cell 8:2539–2551
Dagenais TRT, Keller NP (2009) Pathogenesis of Aspergillus fumigatus in invasive aspergillosis.
Clin Microbiol Rev 22:447–465. https://doi.org/10.1128/CMR.00055- 08
P. Sharma et al.

7 Factors Aecting Drug Resistance andVirulence inFungal Pathogen
Davies DA, Kalinina NA, Samokhvalova LV, Malakhova GV, Scott G, Venning G, Volynskaya
AM, Nesmeyanov VA (2005) Isolation and characterization of the ALP1 protease from
Aspergillus fumigatus and its protein inhibitor from physarium polycephalum. Russ J Bioorg
Chem 31:229–237. https://doi.org/10.1007/s11171- 005- 0032- 6
De Bernardis F, Arancia S, Morelli L, Hube B, Sanglard D, Schäfer W, Cassone A (1999) Evidence
that members of the secretory aspartyl proteinase gene family, in particular SAP2, are virulence
factors for Candida vaginitis. J Infect Dis 179:201–208. https://doi.org/10.1086/314546
Djordjevic J (2010) Role of phospholipases in fungal tness, pathogenicity, and drug develop-
ment–lessons from Cryptococcus neoformans. Front Microbiol 1:125
Drew D, North RA, Nagarathinam K, Tanabe M (2021) Structures and general transport mech-
anisms by the major facilitator superfamily (MFS). Chem Rev 121:5289–5335. https://doi.
org/10.1021/acs.chemrev.0c00983
Eisenman HC, Frases S, Nicola AM, Rodrigues ML, Casadevall A (2009) Vesicle-associated mel-
anization in Cryptococcus neoformans. Microbiology (Reading) 155:3860–3867. https://doi.
org/10.1099/mic.0.032854- 0
Fairlamb AH, Gow NAR, Matthews KR, Waters AP (2016) Drug resistance in eukaryotic microor-
ganisms. Nat Microbiol 1:16092. https://doi.org/10.1038/nmicrobiol.2016.92
Garcia-Effron G, Lee S, Park S, Cleary JD, Perlin DS (2009) Effect of Candida glabrata FKS1 and
FKS2 mutations on echinocandin sensitivity and kinetics of 1,3-β-d-glucan synthase: implica-
tion for the existing susceptibility breakpoint. Antimicrob Agents Chemother 53:3690–3699.
https://doi.org/10.1128/AAC.00443- 09
Gaur M, Puri N, Manoharlal R, Rai V, Mukhopadhayay G, Choudhury D, Prasad R (2008) MFS
transportome of the human pathogenic yeast Candida albicans. BMC Genomics 9:579. https://
doi.org/10.1186/1471- 2164- 9- 579
Ghannoum M, Roilides E, Katragkou A, Petraitis V, Walsh TJ (2015) The role of echinocandins in
Candida biolm-related vascular catheter infections: invitro and invivo model systems. Clin
Infect Dis 61(Suppl 6):S618–S621. https://doi.org/10.1093/cid/civ815
Gulati M, Nobile CJ (2016) Candida albicans biolms: development, regulation, and molecular
mechanisms. Microbes Infect 18:310–321. https://doi.org/10.1016/j.micinf.2016.01.002
Hamed MF, GRdS A, Munzen ME, Reguera-Gomez M, Epstein C, Lee HH, Frases S, Martinez LR
(2023) Phospholipase B is critical for Cryptococcus neoformans survival in the central nervous
system. MBio 14:e0264022. https://doi.org/10.1128/mbio.02640- 22
Hammacott JE, Williams PH, Cashmore AM (2000) Candida albicans CFL1 encodes a func-
tional ferric reductase activity that can rescue a Saccharomyces cerevisiae fre1 mutant the
EMBL accession number for the sequence reported in this paper is AJ387722. Microbiology
146:869–876. https://doi.org/10.1099/00221287- 146- 4- 869
Heinekamp T, Thywissen A, Macheleidt J, Keller S, Valiante V, Brakhage A (2013) Aspergillus
fumigatus melanins: interference with the host endocytosis pathway and impact on virulence.
Front Microbiol 3:440
Hirayama T, Miyazaki T, Sumiyoshi M, Ito Y, Ashizawa N, Takeda K, Iwanaga N, Takazono T,
Yamamoto K, Izumikawa K, Yanagihara K, Makimura K, Tsukamoto K, Kohno S, Mukae H
(2023) Echinocandin resistance in Candida auris occurs in the murine gastrointestinal tract
due to FKS1 mutations. Antimicrob Agents Chemother 67:e0124322. https://doi.org/10.1128/
aac.01243- 22
Hogan DA (2006) Talking to themselves: autoregulation and quorum sensing in fungi. Eukaryot
Cell 5:613–619. https://doi.org/10.1128/ec.5.4.613- 619.2006
Holmes AR, Cardno TS, Strouse JJ, Ivnitski-Steele I, Keniya MV, Lackovic K, Monk BC, Sklar
LA, Cannon RD (2016) Targeting efux pumps to overcome antifungal drug resistance. Future
Med Chem 8:1485–1501. https://doi.org/10.4155/fmc- 2016- 0050
Homer CM, Summers DK, Goranov AI, Clarke SC, Wiesner D, Diedrich JK, Moresco JJ, Toffaletti
D, Upadhya R, Caradonna I, Petnic S, Pessino V, Cuomo CA, Lodge JK, Perfect J, Yates JR,
Nielsen K, Craik CS, Madhani HD (2016) Intracellular action of a secreted peptide required for
fungal virulence. Cell Host Microbe 19:849–864. https://doi.org/10.1016/j.chom.2016.05.001
195

196
Horianopoulos LC, Kronstad JW (2021) Chaperone networks in fungal pathogens of humans. J
Fungi 7:209. https://doi.org/10.3390/jof7030209
Horowitz Brown S, Zarnowski R, Sharpee WC, Keller NP (2008) Morphological transitions gov-
erned by density dependence and lipoxygenase activity in Aspergillus avus. Appl Environ
Microbiol 74:5674–5685. https://doi.org/10.1128/AEM.00565- 08
Horváth P, Nosanchuk JD, Hamari Z, Vágvölgyi C, Gácser A (2012) The identication of gene
duplication and the role of secreted aspartyl proteinase 1in Candida parapsilosis virulence. J
Infect Dis 205:923–933. https://doi.org/10.1093/infdis/jir873
Hossain CM, Ryan LK, Gera M, Choudhuri S, Lyle N, Ali KA, Diamond G (2022) Antifungals and
drug resistance. Encyclopedia 2:1722–1737. https://doi.org/10.3390/encyclopedia2040118
Jiménez-Ortigosa C, Moore C, Denning DW, Perlin DS (2017) Emergence of echinocandin
resistance due to a point mutation in the fks1 gene of Aspergillus fumigatus in a patient with
chronic pulmonary aspergillosis. Antimicrob Agents Chemother 61:e01277-17. https://doi.
org/10.1128/aac.01277- 17
Jung WH, Sham A, White R, Kronstad JW (2006) Iron regulation of the major virulence factors
in the AIDS-associated pathogen Cryptococcus neoformans. PLoS Biol 4:e410. https://doi.
org/10.1371/journal.pbio.0040410
Juvvadi PR, Lee SC, Heitman J, Steinbach WJ (2017) Calcineurin in fungal virulence and drug
resistance: prospects for harnessing targeted inhibition of calcineurin for an antifungal thera-
peutic approach. Virulence 8:186. https://doi.org/10.1080/21505594.2016.1201250
Kaba HE, Nimtz M, Müller PP, Bilitewski U (2013) Involvement of the mitogen activated protein
kinase Hog1p in the response of Candida albicans to iron availability. BMC Microbiol 13:16.
https://doi.org/10.1186/1471- 2180- 13- 16
Kaur R, Ma B, Cormack BP (2007) A family of glycosylphosphatidylinositol-linked aspartyl pro-
teases is required for virulence of Candida glabrata. Proc Natl Acad Sci USA 104:7628–7633.
https://doi.org/10.1073/pnas.0611195104
Kean R, Delaney C, Sherry L, Borman A, Johnson EM, Richardson MD, Rautemaa-Richardson R,
Williams C, Ramage G (2018) Transcriptome assembly and proling of Candida auris reveals
novel insights into biolm-mediated resistance. mSphere 3:e00334-18. https://doi.org/10.1128/
msphere.00334- 18
Keller G, Bird A, Winge DR (2005) Independent metalloregulation of Ace1 and Mac1 in
Saccharomyces cerevisiae. Eukaryot Cell 4:1863–1871. https://doi.org/10.1128/
EC.4.11.1863- 1871.2005
Kernien JF, Snarr BD, Sheppard DC, Nett JE (2018) The interface between fungal biolms and
innate immunity. Front Immunol 8:1968
Kim J-S, Lee K-T, Bahn Y-S (2023) Secreted aspartyl protease 3 regulated by the Ras/cAMP/PKA
pathway promotes the virulence of Candida auris. Fron Cell Infect Microbiol 13:1257897
Kojic EM, Darouiche RO (2004) Candida infections of medical devices. Clin Microbiol Rev
17:255–267. https://doi.org/10.1128/cmr.17.2.255- 267.2004
Kordalewska M, Perlin DS (2019) Identication of drug resistant Candida auris. Front
Microbiol 10:1918
Kryštůfek R, Šácha P, Starková J, Brynda J, Hradilek M, Tloušt’ová E, Grzymska J, Rut W,
Boucher MJ, Drąg M, Majer P, Hájek M, Řezáčová P, Madhani HD, Craik CS, Konvalinka
J (2021) Re-emerging aspartic protease targets: examining Cryptococcus neoformans major
aspartyl peptidase 1 as a target for antifungal drug discovery. J Med Chem 64:6706–6719.
https://doi.org/10.1021/acs.jmedchem.0c02177
Ksiezopolska E, Schikora-Tamarit MÀ, Beyer R, Nunez-Rodriguez JC, Schüller C, Gabaldón
T (2021) Narrow mutational signatures drive acquisition of multidrug resistance in the fun-
gal pathogen Candida glabrata. Curr Biol 31:5314–5326.e10. https://doi.org/10.1016/j.
cub.2021.09.084
Kumari S, Kumar M, Khandelwal NK, Kumari P, Varma M, Vishwakarma P, Shahi G, Sharma S,
Lynn AM, Prasad R, Gaur NA (2018) ABC transportome inventory of human pathogenic yeast
Candida glabrata: phylogenetic and expression analysis. PLoS One 13:e0202993. https://doi.
org/10.1371/journal.pone.0202993
P. Sharma et al.

7 Factors Aecting Drug Resistance andVirulence inFungal Pathogen
Kumari S, Kumar M, Gaur NA, Prasad R (2021) Multiple roles of ABC transporters in yeast.
Fungal Genet Biol 150:103550. https://doi.org/10.1016/j.fgb.2021.103550
Lackner M, Tscherner M, Schaller M, Kuchler K, Mair C, Sartori B, Istel F, Arendrup MC, Lass-
Flörl C (2014) Positions and numbers of FKS mutations in Candida albicans selectively
inuence invitro and invivo susceptibilities to echinocandin treatment. Antimicrob Agents
Chemother 58:3626–3635. https://doi.org/10.1128/AAC.00123- 14
Lamb DC, Kelly DE, Schunck WH, Shyadehi AZ, Akhtar M, Lowe DJ, Baldwin BC, Kelly
SL (1997) The mutation T315A in Candida albicans sterol 14alpha-demethylase causes
reduced enzyme activity and uconazole resistance through reduced afnity. J Biol Chem
272:5682–5688. https://doi.org/10.1074/jbc.272.9.5682
Lamb DC, Kelly DE, White TC, Kelly SL (2000) The R467K amino acid substitution in Candida
albicans sterol 14α-demethylase causes drug resistance through reduced afnity. Antimicrob
Agents Chemother 44:63–67
Lee H, Chang YC, Nardone G, Kwon-Chung KJ (2007) TUP1 disruption in Cryptococcus neofor-
mans uncovers a peptide-mediated density-dependent growth phenomenon that mimics quo-
rum sensing. Mol Microbiol 64:591–601. https://doi.org/10.1111/j.1365- 2958.2007.05666.x
Lev S, Desmarini D, Chayakulkeeree M, Sorrell TC, Djordjevic JT (2012) The Crz1/Sp1 tran-
scription factor of Cryptococcus neoformans is activated by calcineurin and regulates cell wall
integrity. PLoS One 7:e51403. https://doi.org/10.1371/journal.pone.0051403
Li F, Svarovsky MJ, Karlsson AJ, Wagner JP, Marchillo K, Oshel P, Andes D, Palecek SP (2007)
Eap1p, an adhesin that mediates Candida albicans biolm formation in vitro and in vivo.
Eukaryot Cell 6:931–939. https://doi.org/10.1128/EC.00049- 07
Li C, Li Y, Ding C (2019) The role of copper homeostasis at the host-pathogen axis: from bacteria
to fungi. Int J Mol Sci 20:175. https://doi.org/10.3390/ijms20010175
Lin SJ, Pufahl RA, Dancis A, O’Halloran TV, Culotta VC (1997) A role for the Saccharomyces
cerevisiae ATX1 gene in copper trafcking and iron transport. J Biol Chem 272:9215–9220
Liu L, Yu B, Sun W, Liang C, Ying H, Zhou S, Niu H, Wang Y, Liu D, Chen Y (2020) Calcineurin
signaling pathway inuences Aspergillus niger biolm formation by affecting hydrophobicity
and cell wall integrity. Biotechnol Biofuels 13:54. https://doi.org/10.1186/s13068- 020- 01692- 1
Maenchantrarath C, Khumdee P, Samosornsuk S, Mungkornkaew N, Samosornsuk W (2022)
Investigation of uconazole susceptibility to Candida albicans by MALDI-TOF MS and
real-time PCR for CDR1, CDR2, MDR1 and ERG11. BMC Microbiol 22:153. https://doi.
org/10.1186/s12866- 022- 02564- 4
Maligie MA, Selitrennikoff CP (2005) Cryptococcus neoformans resistance to echinocandins:
(1,3)β-glucan synthase activity is sensitive to echinocandins. Antimicrob Agents Chemother
49:2851–2856. https://doi.org/10.1128/aac.49.7.2851- 2856.2005
Martinez LR, Casadevall A (2007) Cryptococcus neoformans biolm formation depends on sur-
face support and carbon source and reduces fungal cell susceptibility to heat, cold, and UV
light. Appl Environ Microbiol 73:4592–4601. https://doi.org/10.1128/AEM.02506- 06
Martinez LR, Casadevall A (2015) Biolm formation by Cryptococcus neoformans. Microbiol
Spectr 3. https://doi.org/10.1128/microbiolspec.mb- 0006- 2014
Mayer FL, Wilson D, Hube B (2013) Candida albicans pathogenicity mechanisms. Virulence
4:119–128. https://doi.org/10.4161/viru.22913
McFadden DC, De Jesus M, Casadevall A (2006) The physical properties of the capsular poly-
saccharides from Cryptococcus neoformans suggest features for capsule construction. J Biol
Chem 281:1868–1875. https://doi.org/10.1074/jbc.M509465200
Mesa-Arango AC, Rueda C, Román E, Quintin J, Terrón MC, Luque D, Netea MG, Pla J, Zaragoza
O (2016) Cell wall changes in amphotericin B-resistant strains from Candida tropicalis and
relationship with the immune responses elicited by the host. Antimicrob Agents Chemother
60:2326–2335. https://doi.org/10.1128/AAC.02681- 15
Missall TA, Moran JM, Corbett JA, Lodge JK (2005) Distinct stress responses of two functional
laccases in Cryptococcus neoformans are revealed in the absence of the thiol-specic antioxi-
dant tsa1. Eukaryot Cell 4:202–208. https://doi.org/10.1128/EC.4.1.202- 208.2005
197

198
Morelli KA, Kerkaert JD, Cramer RA (2021) Aspergillus fumigatus biolms: toward understand-
ing how growth as a multicellular network increases antifungal resistance and disease progres-
sion. PLoS Pathog 17:e1009794. https://doi.org/10.1371/journal.ppat.1009794
Naglik JR, Challacombe SJ, Hube B (2003) Candida albicans secreted aspartyl proteinases in
virulence and pathogenesis. Microbiol Mol Biol Rev 67:400–428. https://doi.org/10.1128/
MMBR.67.3.400- 428.2003
Ni M, Gao N, Kown N-J, Shin K-S, Yu J-H (2010) Regulation of Aspergillus conidiation. In:
Cellular and molecular biology of lamentous fungi. Wiley, Hoboken, pp559–576. https://doi.
org/10.1128/9781555816636.ch35
Nosanchuk JD, Stark RE, Casadevall A (2015) Fungal melanin: what do we know about structure?
Front Microbiol 6:1463
Odom A, Muir S, Lim E, Toffaletti DL, Perfect J, Heitman J (1997) Calcineurin is required for
virulence of Cryptococcus neoformans. EMBO J 16:2576–2589. https://doi.org/10.1093/
emboj/16.10.2576
Padder SA, Prasad R, Shah AH (2018) Quorum sensing: a less known mode of communication
among fungi. Microbiol Res 210:51–58. https://doi.org/10.1016/j.micres.2018.03.007
Papon N, Courdavault V, Clastre M, Bennett RJ (2013) Emerging and emerged pathogenic can-
dida species: beyond the Candida albicans paradigm. PLoS Pathog 9:e1003550. https://doi.
org/10.1371/journal.ppat.1003550
Park M, Do E, Jung WH (2013) Lipolytic enzymes involved in the virulence of human pathogenic
fungi. Mycobiology 41:67–72. https://doi.org/10.5941/MYCO.2013.41.2.67
Park Y-S, Lian H, Chang M, Kang C-M, Yun C-W (2014) Identication of high-afnity copper
transporters in Aspergillus fumigatus. Fungal Genet Biol 73:29–38. https://doi.org/10.1016/j.
fgb.2014.09.008
Perez-Cuesta U, Aparicio-Fernandez L, Guruceaga X, Martin-Souto L, Abad-Diaz-de-Cerio A,
Antoran A, Buldain I, Hernando FL, Ramirez-Garcia A, Rementeria A (2020) Melanin and
pyomelanin in Aspergillus fumigatus: from its genetics to host interaction. Int Microbiol
23:55–63. https://doi.org/10.1007/s10123- 019- 00078- 0
Perlin DS (2015) Echinocandin resistance in Candida. Clin Infect Dis 61:S612–S617. https://doi.
org/10.1093/cid/civ791
Pombeiro-Sponchiado SR, Sousa GS, Andrade JC, Lisboa HF, Gonçalves RCR (2017) Production
of melanin pigment by fungi and its biotechnological applications. In: Melanin. IntechOpen,
London. https://doi.org/10.5772/67375
Pradhan A, Avelar GM, Bain JM, Childers DS, Larcombe DE, Netea MG, Shekhova E, Munro
CA, Brown GD, Erwig LP, Gow NAR, Brown AJP (2018) Hypoxia promotes immune evasion
by triggering β-glucan masking on the Candida albicans cell surface via mitochondrial and
cAMP-protein kinase a signaling. mBio 9:e01318–18. https://doi.org/10.1128/mBio.01318- 18
Prasad R, Rawal MK (2014) Efux pump proteins in antifungal resistance. Front Pharmacol 5:202.
https://doi.org/10.3389/fphar.2014.00202
Prasad R, De Wergifosse P, Goffeau A, Balzi E (1995) Molecular cloning and characterization of
a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifun-
gals. Curr Genet 27:320–329. https://doi.org/10.1007/BF00352101
Prasad T, Chandra A, Mukhopadhyay CK, Prasad R (2006) Unexpected link between iron and
drug resistance of Candida spp.: iron depletion enhances membrane uidity and drug diffu-
sion, leading to drug-susceptible cells. Antimicrob Agents Chemother 50:3597–3606. https://
doi.org/10.1128/AAC.00653- 06
Prasad R, Banerjee A, Khandelwal NK, Dhamgaye S (2015) The ABCs of Candida albicans mul-
tidrug transporter Cdr1. Eukaryot Cell 14:1154–1164. https://doi.org/10.1128/EC.00137- 15
Puri S, Lai WKM, Rizzo JM, Buck MJ, Edgerton M (2014) Iron-responsive chromatin remodel-
ing and MAPK signaling enhance adhesion in Candida albicans. Mol Microbiol 93:291–305.
https://doi.org/10.1111/mmi.12659
Ramage G, Bachmann S, Patterson TF, Wickes BL, López-Ribot JL (2002a) Investigation of
multidrug efux pumps in relation to uconazole resistance in Candida albicans biolms. J
Antimicrob Chemother 49:973–980. https://doi.org/10.1093/jac/dkf049
P. Sharma et al.
Соседние файлы в папке Библиотека им академика М.И. Перельмана
